{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:40:24Z","timestamp":1787010024361,"version":"build-2736575974"},"reference-count":22,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1097\/ico.0b013e31825ec407","type":"journal-article","created":{"date-parts":[[2013,9,20]],"date-time":"2013-09-20T05:04:33Z","timestamp":1379653473000},"page":"1446-1453","source":"Crossref","is-referenced-by-count":22,"title":["Recurrence of Corneal Neovascularization Associated With Lipid Deposition After Subconjunctival Injection of Bevacizumab"],"prefix":"10.1097","volume":"32","author":[{"given":"Hsiao-Sang","family":"Chu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ta-Ching","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fung-Rong","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Li","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-9-20210204","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1136\/bjo.72.12.900","article-title":"Argon laser treatment of lipid keratopathy.","volume":"72","author":"Marsh","year":"1988","journal-title":"Br J Ophthalmol"},{"key":"R2-9-20210204","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1136\/bjo.77.4.248","article-title":". Primary lipid keratopathy: a morphological and biochemical assessment.","volume":"77","author":"Silva-Araujo","year":"1993","journal-title":"Br J Ophthalmol"},{"key":"R3-9-20210204","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1016\/j.ophtha.2010.01.039","article-title":"Corneal neovascularization as a risk factor for graft failure and rejection after keratoplasty: an evidence-based meta-analysis.","volume":"117","author":"Bachmann","year":"2010","journal-title":"Ophthalmology"},{"key":"R4-9-20210204","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1097\/00055735-200108000-00002","article-title":". Corneal neovascularization.","volume":"12","author":"Chang","year":"2001","journal-title":"Curr Opin Ophthalmol"},{"key":"R5-9-20210204","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1167\/iovs.08-1997","article-title":". Subconjunctival injection of bevacizumab (avastin) on corneal neovascularization in different rabbit models of corneal angiogenesis.","volume":"50","author":"Chen","year":"2009","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R6-9-20210204","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1097\/ICO.0b013e3181e458c5","article-title":". Subconjunctival injection of bevacizumab in the treatment of corneal neovascularization associated with lipid deposition.","volume":"30","author":"Chu","year":"2010","journal-title":"Cornea"},{"key":"R7-9-20210204","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1136\/bjo.2006.099887","article-title":". Intravitreal injection of bevacizumab for choroidal neovascularisation associated with pathological myopia.","volume":"91","author":"Sakaguchi","year":"2007","journal-title":"Br J Ophthalmol"},{"key":"R11-9-20210204","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1007\/s00417-009-1067-9","article-title":". One-year results of combined photodynamic therapy and intravitreal bevacizumab injection for retinal pigment epithelial detachment secondary to age-related macular degeneration.","volume":"247","author":"Shima","year":"2009","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R12-9-20210204","doi-asserted-by":"crossref","first-page":"6277","DOI":"10.1167\/iovs.09-4571","article-title":". The different effects of early and late bevacizumab (Avastin) injection on inhibiting corneal neovascularization and conjunctivalization in rabbit limbal insufficiency.","volume":"51","author":"Lin","year":"2010","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R13-9-20210204","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1016\/j.jcrs.2007.07.012","article-title":"Subconjunctival bevacizumab for vascularized rejected corneal grafts.","volume":"33","author":"Awadein","year":"2007","journal-title":"J Cataract Refract Surg"},{"key":"R14-9-20210204","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1007\/s00417-007-0587-4","article-title":"Subconjunctival bevacizumab for corneal neovascularization.","volume":"245","author":"Erdurmus","year":"2007","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R15-9-20210204","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s00417-007-0684-4","article-title":". Bevacizumab (Avastin) eye drops inhibit corneal neovascularization.","volume":"246","author":"Bock","year":"2008","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R16-9-20210204","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1167\/iovs.06-0570","article-title":". Bevacizumab as a potent inhibitor of inflammatory corneal angiogenesis and lymphangiogenesis.","volume":"48","author":"Bock","year":"2007","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R17-9-20210204","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1001\/archopht.125.6.834","article-title":"Topical bevacizumab therapy for corneal neovascularization.","volume":"125","author":"DeStafeno","year":"2007","journal-title":"Arch Ophthalmol"},{"key":"R18-9-20210204","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1097\/01.ico.0000611440.32234.8f","article-title":"Subconjunctival bevacizumab for corneal neovascularization in herpetic stromal keratitis.","volume":"27","author":"Carrasco","year":"2008","journal-title":"Cornea"},{"key":"R19-9-20210204","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1097\/ICO.0b013e31819839f9","article-title":"Subconjunctival and intracorneal bevacizumab injection for corneal neovascularization in lipid keratopathy.","volume":"28","author":"Oh","year":"2009","journal-title":"Cornea"},{"key":"R20-9-20210204","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1089\/jop.2007.0036","article-title":". Role of intravitreal bevacizumab in neovascular glaucoma.","volume":"23","author":"Gheith","year":"2007","journal-title":"J Ocul Pharmacol Ther"},{"key":"R21-9-20210204","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1097\/IJG.0b013e3181aae928","article-title":". Surgical outcomes of intravitreal bevacizumab and guarded filtration surgery in neovascular glaucoma.","volume":"19","author":"Fakhraie","year":"2010","journal-title":"J Glaucoma"},{"key":"R22-9-20210204","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1177\/112067210801800215","article-title":". Bevacizumab-augmented retinal laser photocoagulation in proliferative diabetic retinopathy: a randomized double-masked clinical trial.","volume":"18","author":"Mirshahi","year":"2008","journal-title":"Eur J Ophthalmol"},{"key":"R23-9-20210204","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s00347-004-1140-z","article-title":"Neurotrophic keratitis Article in German.","volume":"102","author":"Cursiefen","year":"2005","journal-title":"Ophthalmologe"},{"key":"R24-9-20210204","doi-asserted-by":"crossref","first-page":"4653","DOI":"10.1167\/iovs.08-2805","article-title":". Bevacizumab application delays epithelial healing in rabbit cornea.","volume":"50","author":"Kim","year":"2009","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R25-9-20210204","doi-asserted-by":"crossref","first-page":"4569","DOI":"10.1167\/iovs.09-4937","article-title":"The inhibitory effects of bevacizumab eye drops on NGF expression and corneal wound healing in rats.","volume":"51","author":"Kim","year":"2010","journal-title":"Invest Ophthalmol Vis Sci"}],"container-title":["Cornea"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/ICO.0b013e31825ec407","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,24]],"date-time":"2021-05-24T15:34:16Z","timestamp":1621870456000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00003226-201311000-00009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11]]},"references-count":22,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/ico.0b013e31825ec407","relation":{},"ISSN":["0277-3740"],"issn-type":[{"value":"0277-3740","type":"print"}],"subject":[],"published":{"date-parts":[[2013,11]]}}}